Starling Oncology, Inc. STLN
3.62 USD -3.08 (-45.97%)
At closeNov 9, 2026, 4:26 AM EST
3.75 +0.13 +3.59%
Pre-market · Nov 9, 4:26 AM ET
3.35 Day range 6.43
2.38 52-week range 7.05
- YTD
- +1.69%
- 1 year
- +1.97%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 502.73M | 393.41M | 324.24M | 252.48M | 203.00M | |
| 76.44M | 54.00M | 59.57M | 52.09M | 40.85M | |
| -36.08M | -60.12M | -77.02M | -81.95M | -45.86M | |
| -60.61M | -64.66M | -83.07M | 68.00K | -10.63M | |
| -50,305.00 | -53,005.00 | -67,877.00 | -0.21 | -0.16 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 33.56M | 49.67M | 33.49M | 14.01M | 115.17M | |
| 164.66M | 172.72M | 209.24M | 261.67M | 203.44M | |
| 180.38M | 169.13M | 152.22M | 138.49M | 99.28M | |
| 103.69M | 123.15M | 119.67M | 108.18M | 183.00K | |
| -15.72M | 3.59M | 57.02M | 123.17M | 104.16M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -24.59M | -26.54M | -36.31M | -61.76M | -32.68M | |
| -3.07M | 46.21M | 62.64M | -131.61M | -12.15M | |
| 11.56M | -3.49M | -6.85M | 92.21M | 154.01M | |
| -3.20M | -3.79M | -4.57M | -5.53M | -2.85M | |
| -16.10M | 16.18M | 19.48M | -101.16M | 109.18M |